Renaissance Technologies’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-447,300
| Closed | -$15M | – | 3577 |
|
|
2026
Q1 | $15M | Buy |
+447,300
| New | +$17.5M | 0.02% | 770 |
|
|
2025
Q3 | – | Sell |
-45,200
| Closed | -$3.79M | – | 3868 |
|
|
2025
Q2 | $3.79M | Buy |
+45,200
| New | +$3.38M | 0.01% | 1695 |
|
|
2023
Q4 | – | Sell |
-61,554
| Closed | -$1.82M | – | 4095 |
|
|
2023
Q3 | $1.82M | Sell |
61,554
-4,500
| -7% | -$27.2K | ﹤0.01% | 1926 |
|
|
2023
Q2 | $283K | Sell |
66,054
-10,461
| -14% | -$45K | ﹤0.01% | 3154 |
|
|
2023
Q1 | $164K | Buy |
76,515
+26,761
| +54% | +$60.1K | ﹤0.01% | 3347 |
|
|
2022
Q4 | $99K | Buy |
49,754
+4,800
| +11% | +$5.97K | ﹤0.01% | 3621 |
|
|
2022
Q3 | $75K | Buy |
44,954
+8,279
| +23% | +$20.2K | ﹤0.01% | 3667 |
|
|
2022
Q2 | $102K | Buy |
36,675
+20,128
| +122% | +$55.7K | ﹤0.01% | 3849 |
|
|
2022
Q1 | $55K | Buy |
16,547
+12,507
| +310% | +$64.8K | ﹤0.01% | 3897 |
|
|
2021
Q4 | $25K | Buy |
4,040
+3,347
| +483% | +$35.1K | ﹤0.01% | 3834 |
|
|
2021
Q3 | $10K | Sell |
693
-24,253
| -97% | -$338K | ﹤0.01% | 3414 |
|
|
2021
Q2 | $427K | Buy |
+24,946
| New | +$421K | ﹤0.01% | 3023 |
|
|
2020
Q3 | – | Sell |
-9,617
| Closed | -$320K | – | 3656 |
|
|
2020
Q2 | $320K | Buy |
9,617
+1,853
| +24% | +$80.3K | ﹤0.01% | 3017 |
|
|
2020
Q1 | $277K | Sell |
7,764
-953
| -11% | -$40.5K | ﹤0.01% | 3007 |
|
|
2019
Q4 | $384K | Sell |
8,717
-1,708
| -16% | -$43.7K | ﹤0.01% | 2987 |
|
|
2019
Q3 | $235K | Buy |
10,425
+898
| +9% | +$28.6K | ﹤0.01% | 3099 |
|
|
2019
Q2 | $400K | Buy |
9,527
+5,285
| +125% | +$183K | ﹤0.01% | 3076 |
|
|
2019
Q1 | $131K | Buy |
+4,242
| New | +$113K | ﹤0.01% | 3271 |
|
|
2017
Q4 | – | Sell |
-354
| Closed | -$14K | – | 3488 |
|
|
2017
Q3 | $14K | Buy |
+354
| New | +$14K | ﹤0.01% | 3163 |
|
Renaissance Technologies's SLNO Position: Q2 2026 in Review
Renaissance Technologies sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 447,300 shares — an estimated $15M sold.
Renaissance Technologies first reported a position in SLNO in Q3 2017 and held it in 19 quarters. The position peaked at $15M in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.
- Renaissance Technologies reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
- Renaissance Technologies sold 447,300 Soleno Therapeutics shares in Q2 2026, an estimated $15M.
- Renaissance Technologies first reported a position in Soleno Therapeutics in Q3 2017 and held it in 19 quarters.
- Renaissance Technologies's Soleno Therapeutics position peaked at $15M in Q1 2026.
- 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.